These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 2484882

  • 21. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3.
    Dustin ML, Olive D, Springer TA.
    J Exp Med; 1989 Feb 01; 169(2):503-17. PubMed ID: 2463330
    [Abstract] [Full Text] [Related]

  • 22. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A.
    Eur J Immunol; 1992 Aug 01; 22(8):2047-53. PubMed ID: 1379184
    [Abstract] [Full Text] [Related]

  • 23. Rosetting of human T lymphocytes with sheep and human erythrocytes. Comparison of human and sheep ligand binding using purified E receptor.
    Selvaraj P, Dustin ML, Mitnacht R, Hünig T, Springer TA, Plunkett ML.
    J Immunol; 1987 Oct 15; 139(8):2690-5. PubMed ID: 3309056
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction.
    Hughes CC, Savage CO, Pober JS.
    J Exp Med; 1990 May 01; 171(5):1453-67. PubMed ID: 1692079
    [Abstract] [Full Text] [Related]

  • 27. Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen.
    Beyers AD, Barclay AN, Law DA, He Q, Williams AF.
    Immunol Rev; 1989 Oct 01; 111():59-77. PubMed ID: 2576418
    [Abstract] [Full Text] [Related]

  • 28. Endothelial cells promote anti-CD3-induced T-cell proliferation via cell-cell contact mediated by LFA-1 and CD2.
    Westphal JR, Willems HW, Tax WJ, Koene RA, Ruiter DJ, De Waal RM.
    Scand J Immunol; 1993 Nov 01; 38(5):435-44. PubMed ID: 7901894
    [Abstract] [Full Text] [Related]

  • 29. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
    Böhmig GA, Kovarik J, Holter W, Pohanka E, Zlabinger GJ.
    J Immunol; 1994 Apr 15; 152(8):3720-8. PubMed ID: 7511657
    [Abstract] [Full Text] [Related]

  • 30. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
    Chong AS, Jiang XL, Scuderi P, Lamas M, Graf LH.
    Cancer Immunol Immunother; 1994 Aug 15; 39(2):127-34. PubMed ID: 7519126
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation.
    Bierer BE, Barbosa J, Herrmann S, Burakoff SJ.
    J Immunol; 1988 May 15; 140(10):3358-63. PubMed ID: 2834437
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation.
    Bierer BE, Peterson A, Barbosa J, Seed B, Burakoff SJ.
    Proc Natl Acad Sci U S A; 1988 Feb 15; 85(4):1194-8. PubMed ID: 2448792
    [Abstract] [Full Text] [Related]

  • 35. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
    Savage CO, Hughes CC, McIntyre BW, Picard JK, Pober JS.
    Transplantation; 1993 Jul 15; 56(1):128-34. PubMed ID: 7687392
    [Abstract] [Full Text] [Related]

  • 36. Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).
    Plunkett ML, Sanders ME, Selvaraj P, Dustin ML, Springer TA.
    J Exp Med; 1987 Mar 01; 165(3):664-76. PubMed ID: 3102675
    [Abstract] [Full Text] [Related]

  • 37. Only dull CD3+ thymocytes bind to thymic epithelial cells. The binding is elicited by both CD2/LFA-3 and LFA-1/ICAM-1 interactions.
    Nonoyama S, Nakayama M, Shiohara T, Yata J.
    Eur J Immunol; 1989 Sep 01; 19(9):1631-5. PubMed ID: 2477252
    [Abstract] [Full Text] [Related]

  • 38. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S, Boumsell L, Dausset J, Degos L, Bernard A.
    Eur J Immunol; 1988 Aug 01; 18(8):1187-94. PubMed ID: 2901355
    [Abstract] [Full Text] [Related]

  • 39. Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3.
    Takai Y, Reed ML, Burakoff SJ, Herrmann SH.
    Proc Natl Acad Sci U S A; 1987 Oct 01; 84(19):6864-8. PubMed ID: 3309949
    [Abstract] [Full Text] [Related]

  • 40. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.
    Huet S, Boumsell L, Raynal B, Degos L, Dausset J, Bernard A.
    Proc Natl Acad Sci U S A; 1987 Oct 01; 84(20):7222-6. PubMed ID: 3118361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.